| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.67B | 51.16B | 25.12B | 19.79B | 15.20B | 13.81B |
| Gross Profit | 4.90B | 7.89B | 4.24B | 3.25B | 2.47B | 2.13B |
| EBITDA | 2.48B | 4.35B | 2.01B | 1.71B | 1.37B | 1.14B |
| Net Income | 2.39B | 4.15B | 2.09B | 518.84M | 312.50M | 199.98M |
Balance Sheet | ||||||
| Total Assets | 31.07B | 57.66B | 32.24B | 20.27B | 16.17B | 15.68B |
| Cash, Cash Equivalents and Short-Term Investments | 5.07B | 13.66B | 6.68B | 4.13B | 3.09B | 3.62B |
| Total Debt | 13.89B | 22.83B | 13.36B | 7.17B | 6.37B | 7.08B |
| Total Liabilities | 22.98B | 40.59B | 24.11B | 14.11B | 11.69B | 11.12B |
| Stockholders Equity | 7.96B | 13.53B | 8.01B | 6.16B | 4.48B | 4.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 738.80M | -2.10B | 1.34B | 230.22M | -473.28M |
| Operating Cash Flow | 0.00 | 4.43B | 292.36M | 2.68B | 1.05B | 777.18M |
| Investing Cash Flow | 0.00 | -2.57B | -4.04B | -2.53B | -392.07M | -1.17B |
| Financing Cash Flow | 0.00 | 3.92B | 6.01B | 888.63M | -867.06M | 770.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥115.23B | 21.77 | 19.59% | 0.16% | 19.44% | 45.06% | |
66 Neutral | ¥1.14T | 12.01 | 7.04% | 1.47% | 3.77% | -0.57% | |
64 Neutral | ¥38.77B | 11.25 | ― | 3.71% | -1.77% | 22.86% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥44.14B | 24.57 | ― | ― | 103.64% | 92.15% | |
56 Neutral | ¥24.82B | 5.28 | ― | 1.57% | 8.92% | 29.98% | |
55 Neutral | ¥1.20T | 18.08 | 6.28% | 1.07% | 5.07% | -24.11% |